Stem Cell Transplantation for Hemoglobinopathies in Dogs
Stem Cell Transplantation for Hemoglobinopathies in Dogs
批准号:
6690207
负责人:
JOHN E HEARST
金额:
$10.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-15 至 2004-01-14
中文摘要
描述(由申请人提供):骨髓移植有可能完全治愈血红蛋白病的疾病症状。对镰状细胞病或地中海贫血患者成功应用错配(相关-单倍体相同)骨髓移植,需要在骨髓中实现同种异体嵌合并稳定,且发病率和死亡率低于现有的错配骨髓移植(BMT)方案。这一目标需要使用更少的全身辐射和更少的药物骨髓消融来支持移植。通过使用补骨脂素光化学处理供体白细胞,混合嵌合骨髓状态已在小鼠中实现并稳定,这些白细胞的增殖能力被阻断,但仍保留其免疫活性。在完全MHC错配的环境下,模型小鼠骨髓移植实验最近证明,在低剂量的清髓辐射条件下,在没有清髓和免疫抑制药物的情况下,S-59(一种补骨脂素)光化学处理(S-59 PCT)的t细胞加回促进和稳定同种异体嵌合,大大降低了移植物抗宿主病(GVHD)的风险。在美国公共卫生服务拨款R01 HL63456“干细胞移植建立AIIochimerism”的支持下,该项目完成了验证,现在进入开发阶段,最终将导致批准儿科同种异体干细胞移植的临床方案。这一成功是奥克兰儿童医院研究所和Cerus公司之间富有成效的合作的结果。这个合作小组现在得出结论,对镰状细胞病或地中海贫血儿科患者进行临床试验的最佳方法需要在西雅图弗雷德·哈钦森医学中心的狗模型中进行移植验证。犬类实验将在该SBIR的第二阶段开始。第一阶段将使用Cerus细胞增殖试验、诱导细胞因子合成试验和诱导表面抗原表达试验对狗白细胞进行S-59光化学治疗的体外验证。当光化学条件被发现可以将狗t细胞的增殖率降低到未经处理的狗t细胞的95%时,I期的具体目标将得到满足。这些细胞必须保持活力。
英文摘要
DESCRIPTION (provided by applicant): Bone marrow transplantation has the potential of providing a complete cure of the disease symptoms of hemoglobinopathies. Successful application of mismatched (related-haploidentical) bone marrow transplantation to patients with sickle cell disease or a thalassemia requires that allochimerism be achieved and stabilized in the bone marrow with less morbidity and mortality than are being experienced in existing mismatched bone marrow transplantation (BMT) protocols. This goal requires use of less total body radiation and less drug myeloablation in support of the transplantation. Mixed chimeric bone marrow states have been achieved and stabilized in mice through the use of psoralen photochemically treated donor leukocytes which are blocked in their proliferative capabilities but which retain their immunological activities. Model mouse bone marrow transplantation experiments, in a complete MHC mismatch setting, have recently demonstrated that under low dose myeloablative radiation conditions and in the absence of myeloablative and immunosuppressive drugs, S-59 (a psoralen) photochemically treated (S-59 PCT) T-cell add-backs promote and stabilize allochimerism with greatly reduced risk of graft versus host disease (GVHD). With the completion of this validation through the support of US Public Health Service Grant R01 HL63456 "Stem Cell Transplantation to Establish AIIochimerism," this project is now entering a development phase that should ultimately lead to an approved clinical protocol of pediatric allogeneic stem cell transplantation. This success has resulted from a very productive collaboration between Children's Hospital Oakland Research Institute and Cerus Corporation. This collaborative team has now concluded that the best approach for access to a clinical test in pediatric patients for sickle cell disease or for thalassemia requires a validation in the dog model for transplantation at the Fred Hutchinson Medical Center in Seattle. The dog experiments will be initiated in Phase II of this SBIR. Phase I will be the in vitro validation of the S-59 photochemical treatment of dog leukocytes using the Cerus cell proliferation assay, the induced cytokine synthesis assay, and the induced surface antigen expression assay. The specific aim of Phase I will be met when the photochemical conditions have been found that are required to reduce the dog T-cell proliferation to 95 percent of untreated dog T-cells. These cells must have retained viability.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Amotosalen PCT of Leukapheresis Units for GvHD Therapy
-
批准号:6787862
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2004
-
负责人:JOHN E HEARST
-
依托单位:
Amotosalen PCT of Leukapheresis Units for GvHD Therapy
-
批准号:7492433
-
项目类别:
-
资助金额:$26.28万
-
财政年份:2004
-
负责人:JOHN E HEARST
-
依托单位:
MINIATURIZED INSTRUMENTATION FOR THE HTS OF DNA REPAIR
-
批准号:6738364
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2004
-
负责人:JOHN E HEARST
-
依托单位:
Cord Blood Stem Cell Transplantation, Hemoglobinopathies
-
批准号:6689114
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2003
-
负责人:JOHN E HEARST
-
依托单位:
DNA Repair Inhibition and Cancer Therapy
-
批准号:6691226
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2003
-
负责人:JOHN E HEARST
-
依托单位:
Validation of Amotosalen-HCI for Clinical Use
-
批准号:6695071
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2003
-
负责人:JOHN E HEARST
-
依托单位:
STEM CELL TRANSPLANTATION--S-59 PHOTOCHEM T CELL
-
批准号:2908629
-
项目类别:
-
资助金额:$25.8万
-
财政年份:1999
-
负责人:JOHN E HEARST
-
依托单位:
STEM CELL TRANSPLANTATION WITH S-59 PHOTOCHEMICALLY TREA
-
批准号:6183982
-
项目类别:
-
资助金额:$25.8万
-
财政年份:1999
-
负责人:JOHN E HEARST
-
依托单位:
STEM CELL TRANSPLANTATION WITH S-59 PHOTOCHEMICALLY TREA
-
批准号:6390530
-
项目类别:
-
资助金额:$25.8万
-
财政年份:1999
-
负责人:JOHN E HEARST
-
依托单位:
STABLE AND DYNAMIC DNA SUPERCOILING IN VIVO
-
批准号:2185372
-
项目类别:
-
资助金额:$19.6万
-
财政年份:1992
-
负责人:JOHN E HEARST
-
依托单位:
STABLE AND DYNAMIC DNA SUPERCOILING IN VIVO
-
批准号:3307360
-
项目类别:
-
资助金额:$17.85万
-
财政年份:1992
-
负责人:JOHN E HEARST
-
依托单位:
STABLE AND DYNAMIC DNA SUPERCOILING IN VIVO
-
批准号:3307361
-
项目类别:
-
资助金额:$18.5万
-
财政年份:1992
-
负责人:JOHN E HEARST
-
依托单位:
DYNAMICS OF DNA MOTION AT PHYSIOLOGICAL CONCENTRATIONS
-
批准号:2181123
-
项目类别:
-
资助金额:$12.42万
-
财政年份:1989
-
负责人:JOHN E HEARST
-
依托单位:
DYNAMICS OF DNA MOTION AT PHYSIOLOGICAL CONCENTRATIONS
-
批准号:2392075
-
项目类别:
-
资助金额:$22.43万
-
财政年份:1989
-
负责人:JOHN E HEARST
-
依托单位:
DYNAMICS OF DNA MOTION AT PHYSIOLOGICAL CONCENTRATIONS
-
批准号:2773891
-
项目类别:
-
资助金额:$1.25万
-
财政年份:1989
-
负责人:JOHN E HEARST
-
依托单位:
DYNAMICS OF DNA MOTION AT PHYSIOLOGICAL CONCENTRATIONS
-
批准号:3300397
-
项目类别:
-
资助金额:$17.46万
-
财政年份:1989
-
负责人:JOHN E HEARST
-
依托单位:
DYNAMICS OF DNA MOTION AT PHYSIOLOGICAL CONCENTRATIONS
-
批准号:3300394
-
项目类别:
-
资助金额:$21.59万
-
财政年份:1989
-
负责人:JOHN E HEARST
-
依托单位:
DYNAMICS OF DNA MOTION AT PHYSIOLOGICAL CONCENTRATIONS
-
批准号:2181124
-
项目类别:
-
资助金额:$20.92万
-
财政年份:1989
-
负责人:JOHN E HEARST
-
依托单位:
DYNAMICS OF DNA MOTION AT PHYSIOLOGICAL CONCENTRATIONS
-
批准号:2181122
-
项目类别:
-
资助金额:$17.6万
-
财政年份:1989
-
负责人:JOHN E HEARST
-
依托单位:
DYNAMICS OF DNA MOTION AT PHYSIOLOGICAL CONCENTRATIONS
-
批准号:3300396
-
项目类别:
-
资助金额:$16.74万
-
财政年份:1989
-
负责人:JOHN E HEARST
-
依托单位:
海外基金